Roger Louis serves as Executive at NOVELION THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Roger Louis has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 9, 2019 involved selling 155 shares valued at $189.
Roger Louis currently holds 1,162 shares of NOVELION THERAPEUTICS INC. (NVLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Louis has been a net neutral trader of NVLN stock. They have purchased $0 and sold $0 worth of shares.
Roger Louis's most recent insider trade was on May 9, 2019, when they sold 155 shares at $1.22 per share.
Get notified when new Form 4 filings are submitted
| $4.26 |
| Discretionary |
| May 9, 2017 | NVLN | $0 | Option Exercise | 547 | $N/A | Discretionary |
| May 9, 2017 | NVLN | $1.5K | Payment | 162 | $9.42 | Discretionary |